Skip to main content
Veterinary Medicines

L.S. POWDER WSP

Authorised
  • Lincomycin hydrochloride
  • Spectinomycin dihydrochloride pentahydrate

Product identification

Medicine name:
Л.С. ПАУДЕР ВРП
L.S. POWDER WSP
Active substance:
  • Lincomycin hydrochloride
  • Spectinomycin dihydrochloride pentahydrate
Target species:
  • Pig
  • Chicken (chick)
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Lincomycin hydrochloride
    222.00
    milligram(s)
    /
    1.00
    gram(s)
  • Spectinomycin dihydrochloride pentahydrate
    444.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral powder
Withdrawal period by route of administration:
  • In drinking water use
    • Pig
      • Meat and offal
        0
        day
    • Chicken (chick)
      • Meat and offal
        5
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF52
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Kepro B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Kepro B.V.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-1772
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 2/09/2023

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 2/09/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."